Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine

Journal of Immunology

Volumn 173, Issue 9, 2004, Pages 5852-5862

  Salerno Gonçalves, Rosângela ^a   Fernandez Viña, Marcelo ^b   Lewinsohn, David M ^c   Sztein, Marcelo B ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIAL PROTEIN; CD1 ANTIGEN; CD1B ANTIGEN; CD1C ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CHAPERONIN; CONCANAMYCIN A; GAMMA INTERFERON; GRANZYME B; HLA ANTIGEN CLASS 1; HLA E ANTIGEN; STRONTIUM; T6 ANTIGEN; TY21A TYPHOID VACCINE; TYPHOID VACCINE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL INFECTION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DISEASE PREDISPOSITION; EFFECTOR CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNIZATION; INTERFERON PRODUCTION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; SALMONELLA ENTERICA; SALMONELLA TYPHI; T LYMPHOCYTE SUBPOPULATION; TARGET CELL DESTRUCTION; VOLUNTEER;

EID: 6344269539     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.9.5852     Document Type: Article

References (47)

1. Levine, M. M., and O. S. Levine. 1997. Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use. Lancet 350:1386.
2. Ivanoff, B., M. M. Levine, and P. H. Lambert. 1994. Vaccination against typhoid fever: present status. Bull. W. H. O. 72:957.
3. Wick, M. J. 2002. The role of dendritic cells during Salmonella infection. Curr. Opin. Immunol. 14:437.
4. Wick, M. J. 2003. The role of dendritic cells in the immune response to Salmonella. Immunol. Lett. 85:99.
5. Gomez-Duarte, O. G., M. F. Pasetti, A. Santiago, M. B. Sztein, S. L. Hoffman, and M. M. Levine. 2001. Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains. Infect. Immun. 69:1192.
6. Pasetti, M. F., R. J. Anderson, F. R. Noriega, M. M. Levine, and M. B. Sztein. 1999. Attenuated δguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses. Clin. Immunol. 92:76.
7. Pasetti, M. F., M. M. Levine, and M. B. Sztein. 2003. Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine 21:401.
8. + T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain CVD 908-htrA. J. Immunol. 170:2734.
9. + effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 169:2196.
10. Sztein, M. B., M. K. Tanner, Y. Polotsky, J. M. Orenstein, and M. M. Levine. 1995. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J. Immunol. 155:3987.
11. Braud, V. M., D. S. Allan, and A. J. McMichael. 1999. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 11:100.
12. Lo, W. F., A. S. Woods, A. DeCloux, R. J. Cotter, E. S. Metcalf, and M. J. Soloski. 2000. Molecular mimicry mediated by MHC class Ib molecules after infection with Gram-negative pathogens. Nat. Med. 6:215.
13. O'Callaghan, C. A., J. Tormo, B. E. Willcox, V. M. Braud, B. K. Jakobsen, D. I. Stuart, A. J. McMichael, J. I. Bell, and E. Y. Jones. 1998. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol. Cell 1:531.
14. Lee, N., D. R. Goodlett, A. Ishitani, H. Marquardt, and D. E. Geraghty. 1998. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:4951.
15. Shawar, S. M., J. M. Vyas, J. R. Rodgers, and R. R. Rich. 1994. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol 12:839.
16. Lee, N., M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. Lopez-Botet, and D. E. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95:5199.
17. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Soderstrom, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795.
18. + T cells. J. Exp. Med. 196:1473.
19. Levine, M. M., C. Ferreccio, P. Abrego, O. S. Martin, E. Ortiz, and S. Cryz. 1999. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17:S22.
20. + T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J. Exp. Med. 187:1633.
21. Stenger, S., R. J. Mazzaccaro, K. Uyemura, S. Cho, P. F. Barnes, J. P. Rosat, A. Sette, M. B. Brenner, S. A. Porcelli, B. R. Bloom, et al. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276:1684.
22. Knox, P. G., A. E. Milner, N. K. Green, A. G. Eliopoulos, and L. S. Young. 2003. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand. J. Immunol. 170:677.
23. Quan, P. C., T. Ishizaka, and B. R. Bloom. 1982. Studies on the mechanism of NK cell lysis. J. Immunol. 128:1786.
24. Braud, V., E. Y. Jones, and A. McMichael. 1997. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27:1164.
25. Kurepa, Z., and J. Forman. 1997. Peptide binding to the class Ib molecule, Qa-1b. J. Immunol. 158:3244.
26. Sunagawa, T., Y. Yonamine, F. Kinjo, M. Watanabe, T. Hibi, and A. Saito. 2001. HLA class-I-restricted and colon-specific cytotoxic T cells from lamina propria lymphocytes of patients with ulcerative colitis. J. Clin. Immunol. 21:381.
27. Hoshino, T., N. Seki, M. Kikuchi, T. Kuramoto, O. Iwamoto, I. Kodama, K. Koufuji, J. Takeda, and K. Itoh. 1997. HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer. Int. J. Cancer 70:631.
28. Nakao, M., H. Yamana, Y. Imai, Y. Toh, U. Toh, A. Kimura, S. Yanoma, T. Kakegawa, and K. Itoh. 1995. HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma. Cancer Res. 55:4248.
29. Menier, C., B. Saez, V. Horejsi, S. Martinozzi, I. Krawice-Radanne, S. Bruel, C. Le Danff, M. Reboul, I. Hilgert, M. Rabreau, et al. 2003. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum. Immunol. 64:315.
30. Walker, B. D. 1990. HIV-1-Specific Cytotoxic T lymphocytes. Stockton Press, New York.
31. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line. J. Immunol 142:3320.
32. Lin, H. S., and S. Gordon. 1979. Secretion of plasminogen activator by bone marrow-derived mononuclear phagocytes and its enhancement by colony-stimulating factor. J. Exp. Med. 150:231.
33. Perez-Villar, J. J., I. Melero, F. Navarro, M. Carretero, T. Bellon, M. Llano, M. Colonna, D. E. Geraghty, and M. Lopez-Botet. 1997. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J. Immunol. 158:5736.
34. Akashi, A., and K. Kuwano. 2002. Fas-mediated lysis of target cell by IL-2 treated cytotoxic T lymphocytes. Kurume Med. J. 49:119.
35. Neighbour, P. A., H. S. Huberman, and Y. Kress. 1982. Human large granular lymphocytes and natural killing ultrastractural studies of strontium-induced degranulation. Eur. J. Immunol 12:588.
36. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726.
37. Houlihan, J. M., P. A. Biro, A. Fergar-Payne, K. L. Simpson, and C. H. Holmes. 1992. Evidence for the expression of non-HLA-A,-B,-C class I genes in the human fetal liver. J. Immunol. 149:668.
38. Llano, M., N. Lee, F. Navarro, P. Garcia, J. P. Albar, D. E. Geraghty, and M. Lopez-Botet. 1998. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28:2854.
39. Borrego, F., M. Ulbrecht, E. H. Weiss, J. E. Coligan, and A. G. Brooks. 1998. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187:813.
40. Seaman, M. S., C. R. Wang, and J. Forman. 2000. MHC class Ib-restricted CTL provide protection against primary and secondary Listeria monocytogenes infection. J. Immunol. 165:5192.
41. Vahdati-Ben Arieh, S., N. Laham, C. Schechter, J. W. Yewdell, J. E. Coligan, and R. Ehrlich. 2003. A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. Blood 101:2858.
42. Fleis, R., T. Filzen, and K. L. Collins. 2002. Species-specific effects of HIV-1 Nef-mediated MHC-I downmodulation. Virology 303:120.
43. Blair, G. E., and M. E. Blair-Zajdel. 2004. Evasion of the immune system by adenoviruses. Curr. Top. Microbiol. Immunol. 273:3.
44. Bubenik, J. 2003. Tumour MHC class 1 downregulation and immunotherapy. Oncol. Rep. 10:2005.
45. Kirveskari, J., Q. He, M. Leirisalo-Repo, O. Maki-Ikola, M. Wuorela, A. Putto-Laurila, and K. Grantors. 1999. Enterobacterial infection modulates major histocompatibility complex class I expression on mononuclear cells. Immunology 97:420.
46. + T-cell memory: only the good ones last. Curr. Opin. Immunol. 16:451.
47. D'Orazio, S. E., M. Velasquez, N. R. Roan, O. Naveiras-Torres, and M. N. Starnbach. 2003. The Listeria monocytogenes lemA gene product is not required for intracellular infection or to activate fMIGWII-specific T cells. Infect. Immun. 71:6721.